(Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | (Q6)Jun 30, 2022 | (Q3)Mar 31, 2022 | (FY)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Turnover | 0.52%274.95B | 3.80%1.14T | 1.01%806.46B | 0.10%541.06B | 3.43%273.54B | 7.48%1.1T | 8.56%798.42B | 10.64%540.5B | 13.05%264.48B | 12.05%1.02T |
Operating income | 0.52%274.95B | 3.80%1.14T | 1.01%806.46B | 0.10%541.06B | 3.43%273.54B | 7.48%1.1T | 8.56%798.42B | 10.64%540.5B | 13.05%264.48B | 12.05%1.02T |
Operating expenses | -0.49%-253.54B | -3.44%-1.02T | -0.52%-732.55B | 0.16%-492.87B | -2.92%-252.29B | -6.90%-985.75B | -8.37%-728.79B | -10.33%-493.65B | -13.20%-245.14B | -11.64%-922.13B |
Gross profit | 0.76%21.41B | 7.01%118.31B | 6.15%73.91B | 2.87%48.19B | 9.88%21.25B | 12.96%110.57B | 10.62%69.63B | 14.00%46.84B | 11.12%19.34B | 16.06%97.88B |
Selling expenses | 5.13%-1.54B | -11.07%-7.38B | -10.91%-4.78B | -14.11%-3.32B | -16.68%-1.62B | -8.06%-6.64B | -3.41%-4.31B | 0.72%-2.91B | 3.02%-1.39B | -8.46%-6.15B |
Administrative expenses | -4.00%-5.86B | -7.28%-23.47B | -9.21%-15.8B | -8.75%-10.54B | -10.53%-5.63B | -5.45%-21.87B | -1.02%-14.47B | 0.32%-9.69B | -2.94%-5.09B | -8.95%-20.74B |
Research and development expenses | 3.64%-2.82B | -6.88%-26.73B | -4.82%-14.72B | 1.23%-8.29B | -1.32%-2.93B | -23.45%-25B | 1.55%-14.05B | 2.34%-8.4B | -10.90%-2.89B | -8.86%-20.25B |
Profit from asset sales | 78.46%40.89M | 783.07%671.46M | 352.54%98M | 466.37%51.95M | 177.27%22.91M | -87.74%76.04M | -91.70%21.66M | -91.59%9.17M | -80.12%8.26M | 5.29%620.42M |
Revaluation surplus | -31.68%31.89M | -39.12%-643.56M | 86.60%-9.67M | 74.04%-12.52M | 638.51%46.67M | -90.20%-462.61M | -430.44%-72.19M | -487.28%-48.21M | -131.16%-8.67M | -329.82%-243.22M |
-Changes in the fair value of other assets | -31.68%31.89M | -39.12%-643.56M | 86.60%-9.67M | 74.04%-12.52M | 638.51%46.67M | -90.20%-462.61M | -430.44%-72.19M | -487.28%-48.21M | -131.16%-8.67M | -329.82%-243.22M |
Impairment and provision | 21.43%-463.94M | -25.22%-9.94B | -25.14%-3.87B | 18.98%-1.95B | 6.53%-590.5M | 19.54%-7.94B | -8.37%-3.09B | -66.81%-2.41B | -24.54%-631.78M | -164.86%-9.87B |
-Other impairment is provision | 21.43%-463.94M | -25.22%-9.94B | -25.14%-3.87B | 18.98%-1.95B | 6.53%-590.5M | 19.54%-7.94B | -8.37%-3.09B | -66.81%-2.41B | -24.54%-631.78M | -164.86%-9.87B |
Special items of operating profit | 116.69%39.65M | 8.18%-3.28B | -21.68%-2.5B | -78.19%-1.45B | -86.29%-237.58M | -510.11%-3.57B | -272.48%-2.05B | -225.10%-814.33M | -223.51%-127.53M | 240.55%869.81M |
Operating profit | 5.06%10.07B | 5.55%43.26B | 2.93%30.08B | 1.28%21.17B | 12.35%9.58B | 6.45%40.98B | 9.82%29.23B | 17.98%20.9B | 14.50%8.53B | 11.53%38.5B |
Financing cost | -23.99%-1.41B | -30.27%-4.66B | -6.85%-2.59B | -0.41%-1.6B | -24.91%-1.14B | 2.86%-3.58B | -0.32%-2.42B | -52.91%-1.59B | -65.72%-911.57M | -5.35%-3.68B |
Special items of earning before tax | -126.89%-19.66M | -44.56%234.44M | 51.97%199.4M | -21.30%149.36M | -43.74%73.11M | 25.48%422.88M | -52.64%131.21M | -13.41%189.78M | 12.17%129.95M | -28.29%337.01M |
Earning before tax | 1.39%8.63B | 2.65%38.83B | 2.82%27.7B | 1.13%19.72B | 9.94%8.52B | 7.60%37.82B | 10.05%26.94B | 15.42%19.5B | 10.44%7.75B | 11.63%35.15B |
Tax | 4.71%-1.54B | -7.78%-6.5B | 8.06%-4.29B | 9.71%-3.23B | -23.99%-1.62B | -3.32%-6.03B | -25.98%-4.67B | -27.89%-3.57B | 4.92%-1.31B | -0.94%-5.84B |
After-tax profit from continuing operations | 2.82%7.09B | 1.68%32.33B | 5.10%23.4B | 3.57%16.49B | 7.09%6.9B | 8.46%31.79B | 7.21%22.27B | 12.95%15.92B | 14.18%6.44B | 14.03%29.32B |
Earning after tax | 2.82%7.09B | 1.68%32.33B | 5.10%23.4B | 3.57%16.49B | 7.09%6.9B | 8.46%31.79B | 7.21%22.27B | 12.95%15.92B | 14.18%6.44B | 14.03%29.32B |
Minority profit | 7.85%1.07B | 21.87%6.23B | 13.80%3.98B | 16.81%2.84B | 20.68%989.59M | 10.57%5.11B | 20.74%3.5B | 35.87%2.43B | 28.97%819.99M | 39.48%4.62B |
Profit attributable to shareholders | 1.98%6.03B | -2.19%26.1B | 3.47%19.42B | 1.18%13.65B | 5.10%5.91B | 8.06%26.68B | 5.01%18.77B | 9.61%13.49B | 12.31%5.62B | 10.26%24.69B |
Basic earnings per share | 2.57%0.399 | -1.70%1.73 | 4.88%1.29 | 2.25%0.91 | 6.87%0.389 | 10.00%1.76 | 6.96%1.23 | 12.66%0.89 | 17.42%0.364 | 6.67%1.6 |
Diluted earnings per share | 2.57%0.399 | -1.70%1.73 | 4.88%1.29 | 2.25%0.91 | 6.87%0.389 | 10.00%1.76 | 6.96%1.23 | 12.66%0.89 | 18.57%0.364 | 11.11%1.6 |
Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion |
Auditor | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) | -- | -- | -- | Deloitte Touche Tohmatsu Certified Public Accountants (Special General Partnership) |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data